CloudCath, a San Francisco, CA-based provider of remote complication monitoring solutions for patients undergoing catheter-based treatments, completed a $12m Series A financing.
The round was led by Capital Integral with participation from FundRx, The Capital Partnership, Coconut Tree Investments, Stanford University’s StartX Fund, and additional strategic and individual investors.
The company intends to use the funds to commercialize its first product and to develop additional applications utilizing the company’s proprietary technology.
Founded in 2017 by CEO Aly ElBadry, and CTO Eric Yu, CloudCath provides a system that enables remote, real-time monitoring for patients undergoing at-home peritoneal dialysis, allowing earlier complication intervention. Its device integrates into the patient’s drain line, monitoring the spent dialysate fluid on every cycle by measuring and quantifying the fluid properties remotely from the patients’ home. The data is transmitted to the CloudCath cloud-based infrastructure in real time, where proprietary data algorithms notify healthcare providers when there is a potential complication escalation. Through CloudCath’s monitoring platform, healthcare providers log in and access real-time data from their patients throughout their treatment, aiding in treatment decision management.